Neuroone Medical Technologies Corp (NMTC)

$0.75 -0.04 (-4.73%)
Market Cap 37.96M
Revenue (ttm) 12.10M
Net Income (ttm) -3.61M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -29.83%
Debt to Equity Ratio 0.00
Volume 75,700
Avg Vol 288,946
Day's Range N/A - N/A
Shares Out 50.53M
Stochastic %K 17%
Beta 0.74
Analysts Strong Sell
Price Target $2.03

Company Profile

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-...

Industry: Medical Devices
Sector: Healthcare
Phone: 952 426 1383
Website: nmtc1.com
Address:
7599 Anagram Drive, Eden Prairie, United States
Ralfidouza
Ralfidouza Mar. 14 at 6:45 PM
As we look ahead, we believe the most exciting commercial opportunities for the NeuroOne platform lie in front of us. Today, we estimate the market opportunity for our currently approved commercial applications to be over $200 million in the U.S. Beyond these indications $NMTC
0 · Reply
IncognitoBull
IncognitoBull Mar. 14 at 2:25 PM
$NMTC voted for the board appts and accounting appts, against the r/s and against the equity plan. They have the ability to get this to compliance organically. Get the partnership inked
0 · Reply
MMM_invest
MMM_invest Mar. 13 at 6:28 PM
$NMTC Just hard to hold this one ... I don't know why, but
0 · Reply
MMM_invest
MMM_invest Mar. 12 at 4:47 PM
$NMTC Nothing burger....
2 · Reply
IncognitoBull
IncognitoBull Mar. 12 at 4:23 PM
$NMTC Rosa mentioned $BSX again. They paid a lot of money for Relievant. BS knows the market is there. They will not want a competitor in the space, especially if ours is better. They will want ours
3 · Reply
IncognitoBull
IncognitoBull Mar. 12 at 3:16 PM
$NMTC heading to an airport, will still try to listen
0 · Reply
IncognitoBull
IncognitoBull Mar. 11 at 8:42 PM
$NMTC
0 · Reply
IncognitoBull
IncognitoBull Mar. 11 at 4:13 PM
$NMTC need news, not regurgitated shareholder letter.
1 · Reply
Ralfidouza
Ralfidouza Mar. 10 at 8:10 PM
NeuroOne is engaged in research and development for drug delivery and spinal cord stimulation programs These solutions offer the potential to reduce the number of hospitalizations and surgical procedures, lower costs, and improve patient outcomes $NMTC
0 · Reply
IncognitoBull
IncognitoBull Mar. 10 at 7:35 PM
$NMTC pretty short blurb, but Press is Press
0 · Reply
Latest News on NMTC
NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript

Mar 12, 2026, 4:02 PM EDT - 3 days ago

NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript

NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript

Feb 17, 2026, 10:24 AM EST - 26 days ago

NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript

NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript

Dec 17, 2025, 11:19 AM EST - 3 months ago

NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript

NeuroOne Medical Technologies Corporation - Special Call

Oct 7, 2025, 10:55 AM EDT - 5 months ago

NeuroOne Medical Technologies Corporation - Special Call

NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025

Sep 8, 2025, 4:05 PM EDT - 6 months ago

NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025

NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

Aug 18, 2025, 8:30 AM EDT - 7 months ago

NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NeuroOne Medical Technologies Corporation (NMTC) Q3 2025 Earnings Call Transcript

Aug 14, 2025, 9:45 AM EDT - 7 months ago

NeuroOne Medical Technologies Corporation (NMTC) Q3 2025 Earnings Call Transcript

NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%

Aug 14, 2025, 7:30 AM EDT - 7 months ago

NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

Jul 31, 2025, 12:12 PM EDT - 8 months ago

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

Jul 31, 2025, 8:30 AM EDT - 8 months ago

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office

Jul 23, 2025, 8:30 AM EDT - 8 months ago

NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office

NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System

Jun 23, 2025, 8:30 AM EDT - 9 months ago

NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary

Jun 3, 2025, 8:30 AM EDT - 10 months ago

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary

NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025

May 29, 2025, 1:05 PM EDT - 10 months ago

NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025

NeuroOne Medical Technologies Corporation (NMTC) Q2 2025 Earnings Call Transcript

May 13, 2025, 9:46 AM EDT - 10 months ago

NeuroOne Medical Technologies Corporation (NMTC) Q2 2025 Earnings Call Transcript

NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%

May 13, 2025, 7:30 AM EDT - 10 months ago

NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%

NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor

May 12, 2025, 8:30 AM EDT - 10 months ago

NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor

NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference

May 5, 2025, 4:01 PM EDT - 11 months ago

NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference

NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time

May 1, 2025, 9:55 AM EDT - 11 months ago

NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

Apr 23, 2025, 9:00 AM EDT - 11 months ago

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NeuroOne® Issues Letter to Shareholders

Apr 16, 2025, 9:00 AM EDT - 11 months ago

NeuroOne® Issues Letter to Shareholders

NeuroOne® OneRF® Technology Success Story Featured on Fox News

Apr 14, 2025, 9:00 AM EDT - 11 months ago

NeuroOne® OneRF® Technology Success Story Featured on Fox News

Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet

Apr 4, 2025, 12:57 PM EDT - 1 year ago

Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

Apr 4, 2025, 8:30 AM EDT - 1 year ago

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

Apr 3, 2025, 4:05 PM EDT - 1 year ago

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - Update

Mar 18, 2025, 1:12 PM EDT - 1 year ago

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - Update

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace

Mar 18, 2025, 9:00 AM EDT - 1 year ago

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace

NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy

Mar 18, 2025, 8:46 AM EDT - 1 year ago

NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy

NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

Mar 11, 2025, 9:00 AM EDT - 1 year ago

NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Mar 5, 2025, 9:00 AM EST - 1 year ago

NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

NeuroOne Medical Technologies Corporation (NMTC) Q1 2025 Earnings Call Transcript

Feb 12, 2025, 10:18 AM EST - 1 year ago

NeuroOne Medical Technologies Corporation (NMTC) Q1 2025 Earnings Call Transcript

NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update

Feb 12, 2025, 8:00 AM EST - 1 year ago

NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time

Feb 5, 2025, 11:00 AM EST - 1 year ago

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time

NeuroOne® Regains Compliance with Nasdaq Listing Requirements

Feb 4, 2025, 10:56 AM EST - 1 year ago

NeuroOne® Regains Compliance with Nasdaq Listing Requirements

NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million

Jan 10, 2025, 8:30 AM EST - 1 year ago

NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million

Stock Picks From Seeking Alpha's December 2024 New Analysts

Jan 7, 2025, 8:00 AM EST - 1 year ago

Stock Picks From Seeking Alpha's December 2024 New Analysts

ALGM CE CEG DOCS ETD FDVV FSS

NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST

Jan 3, 2025, 8:30 AM EST - 1 year ago

NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST

NeuroOne Medical Technologies Corporation (NMTC) Q4 2024 Earnings Call Transcript

Dec 17, 2024, 9:42 AM EST - 1 year ago

NeuroOne Medical Technologies Corporation (NMTC) Q4 2024 Earnings Call Transcript

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

Dec 17, 2024, 8:30 AM EST - 1 year ago

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

NeuroOne Medical Technologies: A Small-Cap Electrode Technology Play With Multiple Catalysts Ahead

Dec 10, 2024, 3:15 AM EST - 1 year ago

NeuroOne Medical Technologies: A Small-Cap Electrode Technology Play With Multiple Catalysts Ahead

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

Nov 13, 2024, 9:30 AM EST - 1 year ago

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System

Oct 31, 2024, 4:01 PM EDT - 1 year ago

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference

Sep 24, 2024, 9:30 AM EDT - 1 year ago

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland

Sep 10, 2024, 9:00 AM EDT - 1 year ago

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 5, 2024, 6:23 PM EDT - 1 year ago

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

NeuroOne Medical Technologies Corporation (NMTC) Q3 2024 Earnings Call Transcript

Aug 14, 2024, 7:21 PM EDT - 1 year ago

NeuroOne Medical Technologies Corporation (NMTC) Q3 2024 Earnings Call Transcript

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Aug 14, 2024, 4:00 PM EDT - 1 year ago

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

Aug 12, 2024, 11:30 AM EDT - 1 year ago

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

Jun 20, 2024, 9:30 AM EDT - 1 year ago

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

NeuroOne Medical Technologies Corporation (NMTC) Q2 2024 Earnings Call Transcript

May 14, 2024, 9:48 PM EDT - 1 year ago

NeuroOne Medical Technologies Corporation (NMTC) Q2 2024 Earnings Call Transcript

Ralfidouza
Ralfidouza Mar. 14 at 6:45 PM
As we look ahead, we believe the most exciting commercial opportunities for the NeuroOne platform lie in front of us. Today, we estimate the market opportunity for our currently approved commercial applications to be over $200 million in the U.S. Beyond these indications $NMTC
0 · Reply
IncognitoBull
IncognitoBull Mar. 14 at 2:25 PM
$NMTC voted for the board appts and accounting appts, against the r/s and against the equity plan. They have the ability to get this to compliance organically. Get the partnership inked
0 · Reply
MMM_invest
MMM_invest Mar. 13 at 6:28 PM
$NMTC Just hard to hold this one ... I don't know why, but
0 · Reply
MMM_invest
MMM_invest Mar. 12 at 4:47 PM
$NMTC Nothing burger....
2 · Reply
IncognitoBull
IncognitoBull Mar. 12 at 4:23 PM
$NMTC Rosa mentioned $BSX again. They paid a lot of money for Relievant. BS knows the market is there. They will not want a competitor in the space, especially if ours is better. They will want ours
3 · Reply
IncognitoBull
IncognitoBull Mar. 12 at 3:16 PM
$NMTC heading to an airport, will still try to listen
0 · Reply
IncognitoBull
IncognitoBull Mar. 11 at 8:42 PM
$NMTC
0 · Reply
IncognitoBull
IncognitoBull Mar. 11 at 4:13 PM
$NMTC need news, not regurgitated shareholder letter.
1 · Reply
Ralfidouza
Ralfidouza Mar. 10 at 8:10 PM
NeuroOne is engaged in research and development for drug delivery and spinal cord stimulation programs These solutions offer the potential to reduce the number of hospitalizations and surgical procedures, lower costs, and improve patient outcomes $NMTC
0 · Reply
IncognitoBull
IncognitoBull Mar. 10 at 7:35 PM
$NMTC pretty short blurb, but Press is Press
0 · Reply
IncognitoBull
IncognitoBull Mar. 10 at 12:38 AM
$BSX $NMTC Neuro One has an electrode that diagnosis and ablates in the same procedure. BS bought Relievant's basivertbral ablation system in 2023 for 850M. At that time, Relievant was the only FDA approved device. Our device is going to compete for the market very soon. .80 per share.
0 · Reply
IncognitoBull
IncognitoBull Mar. 10 at 12:13 AM
$NMTC he has never done this before....goven examples of other company acquisitions. If it were us....850M/50M shares = $17 SP. I'd like to ask him how our BV Ablation device compares to theirs. How far along are they in development compared to ours, etc.
1 · Reply
IncognitoBull
IncognitoBull Mar. 9 at 11:15 PM
$NMTC this is the new podcast, I posted a previous one. Listening now https://open.spotify.com/show/32CvtseLj3KknqYDFdO7P3
0 · Reply
IncognitoBull
IncognitoBull Mar. 9 at 10:38 PM
$NMTC podcast link. I am halfway thru it. Nothing "new" so far, but, personally, I still feel like Mar 12th should give update on new partnerships, get time to uptrend to $1, hold for 10 days, cancel the r/s vote. In a better market... I'd be more confident, but it just is a terrible year. https://medtechimpactpodcast.com/advancing-neuroscience-with-dave-rosa-of-neuroone/
0 · Reply
IncognitoBull
IncognitoBull Mar. 9 at 10:12 PM
$NMTC https://ir.nmtc1.com/press-release-details?newsId=5449d7efa2f83848aaa403986c8b560034e36b039c55fbd7e451cc4539133dc2
0 · Reply
IncognitoBull
IncognitoBull Mar. 9 at 10:10 PM
$NMTC
0 · Reply
IncognitoBull
IncognitoBull Mar. 9 at 10:08 PM
$NMTC a shareholder letter has been released and it is all amazing news. Sadly, this market/economy and the last capital raise has hurt sentiment. It does state an April 3rd vote to aporove an r/s. It also states the board can choose to not do it, if it is not needed. We need news of contracts and partnerships, holders vs flippers. We need buyers to have reason to stick around.
0 · Reply
IncognitoBull
IncognitoBull Mar. 6 at 4:32 PM
$NMTC bet he has some buddies buying too....
0 · Reply
IncognitoBull
IncognitoBull Mar. 6 at 3:55 PM
$NMTC 👁 🧐
0 · Reply
IncognitoBull
IncognitoBull Mar. 5 at 8:31 PM
$NMTC Rosa said, in the last ER, that compliance was his goal, cash to cover thru end of fiscal 2026 (Sept) but he also said that he still didn't think they'd have to dilute again (Sept 26) if the additional partnerships start signing up.
0 · Reply
Babybulltrader
Babybulltrader Mar. 4 at 9:26 PM
$NMTC CEO bought 1 million shares whats going on
1 · Reply
IncognitoBull
IncognitoBull Mar. 4 at 6:51 PM
$NMTC
0 · Reply